Advertisement
Advertisement
OBIO
Orchestra BioMed Holdings, Inc. Ordinary Shares
3.83
USDSponsored
+0.08
+2.27%
Jul 27, 13:36 UTC -4
Open
OBIO Earnings Reports
Positive Surprise Ratio
OBIO beat 11 of 13 last estimates.
85%
Next Report
Date of Next Report
Aug 18, 2026
Estimate for Q2 26 (Revenue/ EPS)
$123.83K
/-$0.39
Implied change from Q1 26 (Revenue/ EPS)
+12.57%
/+18.18%
Implied change from Q2 25 (Revenue/ EPS)
-85.19%
/-22.00%
Orchestra BioMed Holdings, Inc. Ordinary Shares earnings per share and revenue
On May 12, 2026, OBIO reported earnings of -0.33 USD per share (EPS) for Q1 26, beating the estimate of -0.43 USD, resulting in a 24.93% surprise. Revenue reached 110.00 thousand, compared to an expected 194.56 thousand, with a -43.46% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.39 USD, with revenue projected to reach 123.83 thousand USD, implying an increase of 18.18% EPS, and increase of 12.57% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
NovoCure Limited Ordinary Shares
Report Date
Jul 23, 2026 For Q2 26
Estimate
-$0.33
Actual
-$0.13
Surprise
+61.70%
DBV Technologies S.A.
Report Date
Jul 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.60
Surprise
-494.06%
argenx SE - ADR
Report Date
Jul 23, 2026 For Q2 26
Estimate
$6.29
Actual
$7.32
Surprise
+16.38%
Lexaria Bioscience Corp. Common Stock
Report Date
Jul 13, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+7.73%
VivoSim Labs, Inc. Common Stock
Report Date
Jul 14, 2026 For Q4 25
Estimate
-$0.19
Actual
-$2.21
Surprise
-1,040.35%
FAQ
What were Orchestra BioMed Holdings, Inc. Ordinary Shares's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Orchestra BioMed Holdings, Inc. Ordinary Shares reported EPS of -$0.33, beating estimates by 24.93%, and revenue of $110.00K, -43.46% below expectations.
How did the market react to Orchestra BioMed Holdings, Inc. Ordinary Shares's Q1 2026 earnings?
The stock price moved -- 0%, changed from $4.06 before the earnings release to $4.06 the day after.
When is Orchestra BioMed Holdings, Inc. Ordinary Shares expected to report next?
The next earning report is scheduled for Aug 18, 2026.
What are the forecasts for Orchestra BioMed Holdings, Inc. Ordinary Shares's next earnings report?
Based on --
analysts, Orchestra BioMed Holdings, Inc. Ordinary Shares is expected to report EPS of -$0.39 and revenue of $123.83K for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement